Show simple item record

In Vivo Efficacy of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Uncomplicated Falciparum Malaria: an Open-Randomized, Non-Inferiority Clinical Trial in South Kivu, Democratic Republic of Congo

dc.contributor.authorde Wit, M
dc.contributor.authorFunk, AL
dc.contributor.authorMoussally, K
dc.contributor.authorNkuba, DA
dc.contributor.authorSiddiqui, R
dc.contributor.authorBil, K
dc.contributor.authorPiriou, E
dc.contributor.authorBart, A
dc.contributor.authorBahizi Bizoza, P
dc.contributor.authorBousema, T
dc.date.accessioned2016-09-15T15:14:26Z
dc.date.available2016-09-15T15:14:26Z
dc.date.issued2016
dc.date.submitted2016-09-06
dc.identifier.citationIn vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo. 2016, 15:455 Malar. J.en
dc.identifier.issn1475-2875
dc.identifier.pmid27599612
dc.identifier.doi10.1186/s12936-016-1444-x
dc.identifier.urihttp://hdl.handle.net/10144/618655
dc.description.abstractBetween 2009 and 2012, malaria cases diagnosed in a Médecins sans Frontières programme have increased fivefold in Baraka, South Kivu, Democratic Republic of the Congo (DRC). The cause of this increase is not known. An in vivo drug efficacy trial was conducted to determine whether increased treatment failure rates may have contributed to the apparent increase in malaria diagnoses.
dc.language.isoenen
dc.publisherBioMed Central (Springer Science)en
dc.rightsPublished by BioMed Central, [url]http://www.malariajournal.com/[/url] Archived on this site by Open Access permissionen
dc.titleIn Vivo Efficacy of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Uncomplicated Falciparum Malaria: an Open-Randomized, Non-Inferiority Clinical Trial in South Kivu, Democratic Republic of Congoen
dc.identifier.journalMalaria Journalen
refterms.dateFOA2019-03-04T12:50:33Z
html.description.abstractBetween 2009 and 2012, malaria cases diagnosed in a Médecins sans Frontières programme have increased fivefold in Baraka, South Kivu, Democratic Republic of the Congo (DRC). The cause of this increase is not known. An in vivo drug efficacy trial was conducted to determine whether increased treatment failure rates may have contributed to the apparent increase in malaria diagnoses.


Files in this item

Thumbnail
Name:
de Wit et al - 2016 - In Vivo ...
Size:
1.448Mb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record